title: In vitro interactions of approved and experimental drugs against Candida drugs against Candida spp.
authors.affiliation: Cancer Research Institute, Arizona State University, Tempe. Arizona 85287-2404, USA.
authors.forename: K K
authors.initials: KK
authors.lastname: Repp
authors.forename: F
authors.initials: F
authors.lastname: Hogan
authors.forename: G R
authors.initials: GR
authors.lastname: Pettit
authors.forename: R K
authors.initials: RK
authors.lastname: Pettit
mesh_terms: D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D001230:Aspergillus / Q000187:drug effects*; D001555:Benzene Derivatives / Q000494:pharmacology; D002176:Candida albicans / Q000187:drug effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005030:Ethylenes / Q000494:pharmacology; D005437:Flucytosine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D009842:Oligopeptides / Q000494:pharmacology
chemical_list: C462659:1-(3',4',5'-trimethoxyphenyl)-2-nitroethylene; D000935:Antifungal Agents; D001555:Benzene Derivatives; D005030:Ethylenes; D009842:Oligopeptides; C482455:auristatin PHE; D000666:Amphotericin B; D005437:Flucytosine